Scribd Logo
Upload

Welcome to Scribd!

  • 798 views

    Drug Study-Med Ward

    Uploaded by

    Ernest Brian Fernandez
    The document summarizes information about the drug Tranexamic Acid being prescribed to a 62-year-old patient with an admitting diagnosis of upper gastrointestinal bleeding. It lists the generic and brand names, dosage, and date ordered of the drug. It then provides information on the drug's mechanism of action as an antifibrinolytic that inhibits plasminogen activator to prevent fibrinolysis and blood clot breakdown. Contraindications and side effects are listed. Nursing responsibilities are outlined.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd

    Drug Study-Med Ward

    Uploaded by

    Ernest Brian Fernandez
    798 views2 pages
    The document summarizes information about the drug Tranexamic Acid being prescribed to a 62-year-old patient with an admitting diagnosis of upper gastrointestinal bleeding. It lists the generic and brand names, dosage, and date ordered of the drug. It then provides information on the drug's mechanism of action as an antifibrinolytic that inhibits plasminogen activator to prevent fibrinolysis and blood clot breakdown. Contraindications and side effects are listed. Nursing responsibilities are outlined.

    Original Description:

    Medical ward drug study

    Original Title

    Drug Study-med Ward

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The document summarizes information about the drug Tranexamic Acid being prescribed to a 62-year-old patient with an admitting diagnosis of upper gastrointestinal bleeding. It lists the generic and brand names, dosage, and date ordered of the drug. It then provides information on the drug's mechanism of action as an antifibrinolytic that inhibits plasminogen activator to prevent fibrinolysis and blood clot breakdown. Contraindications and side effects are listed. Nursing responsibilities are outlined.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    798 views2 pages

    Drug Study-Med Ward

    Uploaded by

    Ernest Brian Fernandez
    The document summarizes information about the drug Tranexamic Acid being prescribed to a 62-year-old patient with an admitting diagnosis of upper gastrointestinal bleeding. It lists the generic and brand names, dosage, and date ordered of the drug. It then provides information on the drug's mechanism of action as an antifibrinolytic that inhibits plasminogen activator to prevent fibrinolysis and blood clot breakdown. Contraindications and side effects are listed. Nursing responsibilities are outlined.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 2

    Patient Initials: Drug Name Generic Name: Tranexamic Acid Brand Name: Transamin Dosage: Route: Date ordered:

    September 19 2013

    J.C.R. Classification

    Age: 62 years old Mechanism of Action

    Admitting Diagnosis: Upper Gastrointestinal Bleeding Contraindication Side Effects Nursing Responsibilities Unusual change in bleeding pattern should be immediately reported to the physician. For women who are taking Tranexamic acid to control heavy bleeding, the medication should only be taken during the menstrual period. The medication can be taken with or without meals.

    Indication Tranexamic acid is used for the prompt and effective control of hemorrhage in various surgical and clinical areas: epistaxis, hemoptysis, hematuria, peptic ulcer with hemorrhage and blood dyscrasias with hemorrhage

    Anti-fibrinolytic, Tranexamic antihemorrhagic acid is a synthetic derivative of the amino acid lysine. It exerts its antifibrinolytic effect through the reversible blockade of lysine-binding sites on plasminogen molecules. Antifibrinolytic drug inhibits endometrial plasminogen activator and thus prevents fibrinolysis and

    Severe Allergic reaction allergic to the drug or reactions hypersensitivity such as rash, hives, Presence of blood itching, clots (eg, in the dyspnea, leg, lung, eye, tightness in brain), have a the chest, history of blood swelling of clots, or are at the mouth, risk for blood face, lips or clots tongue Calf pain, Current swelling or administration of tenderness factor IX complex Chest pain concentrates or Confusion anti-inhibitor Coughing coagulant up blood concentrates # Decreased urination Severe or

    the breakdown of blood clots. The plasminogenplasmin enzyme system is known to cause coagulation defects through lytic activity on fibrinogen, fibrin and other clotting factors. By inhibiting the action of plasmin (finronolysin) the antifibrinolytic agents reduce excessive breakdown of fibrin and effect physiological hemostasis.

    persistent headache Severe or persistent body malaise Shortness of breath Slurred speech Slurred speech Vision changes

    Swallow Tranexamic Acid whole with plenty of liquids. Do not break, crush, or chew before swallowing. If you miss a dose of Tranexamic Acid, take it when you remember, then take your next dose at least 6 hours later. Do not take 2 doses at once

    You might also like